Compared with a year ago, Silver Ring Value Partners' portfolio is more undervalued and better balanced. Click here to read ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

Chief Medical Officer, David Lebwohl ... dosed at the highest level of 50mg continue to be attack free since the end of the ...

From the sale of Delta Private Jets to Wheels Up in 2019, through the premature reports of its demise, and what's next, four ...

Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...

A share of our veterans suffer from injuries and conditions that will shadow them — and their families —for the rest of their ...

After an attempt to decriminalize drugs made the addiction crisis in Oregon even worse, local Christians are pleading with ...

TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer ...

Q3 2024 Earnings Call Transcript November 4, 2024 Tactile Systems Technology, Inc. beats earnings expectations. Reported EPS ...

A reported bid by the major parties to rush donation reforms through parliament before Christmas should be seen as a cynical ...

Joining me from Dynavax are Ryan Spencer, chief executive officer; Donn Casale, chief commercial officer; Rob Janssen, chief medical officer ... This quarter, we read out our phase 1 extension study ...

We look forward to initiating an adaptive platform trial, starting with sub-study 1 randomizing patients with relapsed PSOC to single agent COM701 maintenance treatment or placebo in the second ...